Clinical Research Directory
Browse clinical research sites, groups, and studies.
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
Sponsor: Urological Research Network, LLC
Summary
Registration of Prostate Cancer patients undergoing Prostate Cryotherapy guided by Mutiparametric-MRI (MP-MRI) highlighting biopsy confirmed regions. The primary outcome measure is 5 year oncological control. Secondary aim is lack of progression beyond the prostate gland. The aim of intervention is to eradicate prostate cancer disease in the treated area while imposing no or minimal deleterious effects in quality of life.
Official title: Office Based MRI/Ultrasound Guided Prostate Cryotherapy: Outcomes Registry
Key Details
Gender
MALE
Age Range
55 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2013-08
Completion Date
2033-08
Last Updated
2023-01-26
Healthy Volunteers
No
Conditions
Interventions
FUSE IMAGE MRI GUIDED PROSTATE CRYOTHERAPY
Biopsy proven Prostate Cancer is delimited and defined by MP-MRI. The MRI study is fused with transrectal ultrasound in realtime. The cryogenic "cryoprobes/devices" are employed to freeze and all "circuled or noted" cancer lesions. Two freeze 8 min/ thaw 10 min clycles are performed. Thermocouples are used to monitor treatment areas and safety margins
Locations (1)
Urological Research Network
Miami Lakes, Florida, United States